Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE)

67 filings reported holding GLUE - Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Monte Rosa Therapeutics, Inc. - Common Stock, par value $0.0001 per share (GLUE) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 39.9M shares of 61.2M outstanding shares and own 65.15% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (7.69M shares), FMR LLC (5.34M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.1M shares), BAKER BROS. ADVISORS LP (4.92M shares), Avoro Capital Advisors LLC (4.54M shares), BlackRock Inc. (2.31M shares), VANGUARD GROUP INC (1.64M shares), Aisling Capital Management LP (1.47M shares), Alphabet Inc. (1.46M shares), and CITADEL ADVISORS LLC (980K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.